Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 42 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Efstratiou, Ioannis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Iliadis, A., Virvili M-A., Flaris N. A., Pervana S., Pazarli E., Tripsianis G., et al. (2018).  PTTG-1 (Securin) immunoexpression in meningiomas correlates with tumor grade and proliferation rate: potential use as a diagnostic marker of malignancy.. APMIS. 126(4), 295-302.
Fountzilas, E., Kotoula V., Tikas I., Manousou K., Papadopoulou K., Poulios C., et al. (2018).  Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.. Oncotarget. 9(86), 35623-35638.
Pentheroudakis, G., Kotoula V., Eleftheraki A. G., Tsolaki E., Wirtz R. M., Kalogeras K. T., et al. (2013).  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).. PLoS One. 8(7), e70634.
Ioannou, H. P., Fotoulaki M., Pavlitou A., Efstratiou I., & Augoustides-Savvopoulou P. (2011).  Plasma citrulline levels in paediatric patients with celiac disease and the effect of a gluten-free diet.. Eur J Gastroenterol Hepatol. 23(3), 245-9.
Fotoulaki, M., Panagopoulou P., Efstratiou I., & Nousia-Arvanitakis S. (2007).  Pitfalls in the approach to pica.. Eur J Pediatr. 166(6), 623-4.
Kotoula, V., Lakis S., Tikas I., Giannoulatou E., Lazaridis G., Papadopoulou K., et al. (2019).  Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.. Gynecol Oncol. 152(2), 375-386.
Koumarianou, A., Karayannopoulou G., Gourgioti G., Batistatou A., Bobos M., Efstratiou I., et al. (2015).  PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.. Cancer Chemother Pharmacol. 75(6), 1289-301.
Fountzilas, G., Kourea H. P., Bobos M., Televantou D., Kotoula V., Papadimitriou C., et al. (2011).  Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.. Anticancer Res. 31(9), 3007-18.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.